BNP Paribas Asset Management’s Elanco Animal Health ELAN Stock Holding History
Bought
Maintained
Sold
Other funds holding ELAN
VPM
VCM
BNP Paribas Asset Management's ELAN Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Elanco Animal Health (ELAN) stake by 34% in Q1 2026, buying an estimated $60.8K and bringing the position to 9,897 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1332.
BNP Paribas Asset Management first reported a position in ELAN in Q2 2019 and has held it in 10 quarters since. The position peaked at $13M in Q4 2022. 516 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.
- BNP Paribas Asset Management held 9,897 shares of Elanco Animal Health worth $237K as of Q1 2026.
- BNP Paribas Asset Management bought 2,488 Elanco Animal Health shares in Q1 2026, an estimated $60.8K.
- Elanco Animal Health made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1332 holding.
- BNP Paribas Asset Management first reported a position in Elanco Animal Health in Q2 2019 and has held it in 10 quarters since.
- BNP Paribas Asset Management's Elanco Animal Health position peaked at $13M in Q4 2022.
- 516 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.